Bing Hou

Title: Innovations and Contributions of Inventor Bing Hou

Introduction

Bing Hou is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic and diagnostic purposes. With a total of 5 patents, his work has had a notable impact on medical research and treatment options.

Latest Patents

Bing Hou's latest patents include innovative antibodies specific to folate receptor alpha, also known as folate receptor 1 or FOLR1. These antibodies have potential uses in both therapeutic and diagnostic applications. Additionally, he has developed chimeric antigen receptors (CARs) that incorporate an extracellular antigen-binding fragment targeting FOLR1, which can be expressed by immune cells. Another significant patent involves antibodies specific to MUC18, also referred to as MCAM or CD146, along with their therapeutic and diagnostic applications. Similar to his work with FOLR1, he has also created CARs that bind MUC18 and can be utilized by immune cells.

Career Highlights

Throughout his career, Bing Hou has worked with notable companies such as Multitude, Inc. and Antengene Discovery Limited. His experience in these organizations has allowed him to further his research and development efforts in the biotechnology sector.

Collaborations

Bing Hou has collaborated with esteemed colleagues, including Xun Meng and Shu-Hui Liu. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Bing Hou's innovative work in the field of biotechnology, particularly with antibodies and CARs, showcases his dedication to advancing medical science. His contributions are paving the way for new therapeutic and diagnostic solutions.